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Introduction
Lately, parasitic diseases have returned in force in medi-
cal practice putting major problems of diagnosis, treatment 
and evolution [1,2]. The geographical study of parasitosis 
as well as the high number of human diseases justify the 
involvement of substantial resources to prevent and exert 
effective control of these infections [3,4].
Toxocariasis is a term representing human infection 
caused by larvae of helminths of the genus Toxocara that 
parasites in dogs (Toxocara canis), cats (Toxocara cati) [5], 
and possible in horned animals (Toxocara vitulorum) and 
swine [6]. Definitive host is shown by the above-mentioned 
animals, but once they enter the human body it can lead to 
bad consequences.
Toxocara canis and cati, being the most common intes-
tinal parasites have a variety of random hosts including hu-
mans, birds, pigs, rodents, monkeys and rabbits. The man 
is infected by the ingestion of T. canis or T. cati embryonic 
eggs. Larvae hatch in the intestine of the intermediate host 
without the ability to fully mature and remain throughout 
the infected period at the second stage of development. The 
degree of the intermediate host damage depends on the 
amount of larvae circulating through the bloodstream and 
the affected organs, as well as on the immune response of 
the host [7]. Of course, it is much more difficult to establish 
the diagnosis of Toxocariasis in those with whom the dis-
ease is asymptomatic or discrete, even if it can evolve for a 
long time, sometimes up to several decades [8].
Transmission to humans most often occurs through the 
ingestion of toxocara eggs. Toxocara canis has an ability to 
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Abstract
Background: Toxocariasis is a clinical notion that reflects human involvement with the Toxocara larvae in the second stage of development. Its typical 
syndromes are Larvae Migrans Visceralis, ocular toxocarosis , neurological form and occult form. The most common toxocariasis is asymptomatic, only 
eosinophilia and the positive serological result being the only manifestations of this helminth. The epidemiological examination and a detailed anamnesis 
of the patient can be helpful in establishing this diagnosis. Children are part of the risk group, especially because of the childhood habits, their undoubted 
attraction to puppies, and because of their low immune system.
Material and methods: The elaborated prospective-descriptive study presents the evolution features in a group of 94 children with T.canis monoinvasion 
in which were examined the clinical signs, important laboratory indices, the applied treatment and its influence.
Results: The study revealed the most common clinical signs and paraclinical changes in a group of 94 children with T.canis monoinvasion. Was examined 
the specific treatment by highlighting its influence on laboratory indices representative for this parasitosis. 
Conclusions: The most common clinical signs were headache, dry cough and abdominal pain. The specific therapy for vicerial chronic toxocariasis 
in children was far superior in clinical outcomes, this being reflected by maintaining ALT levels within the normal values demonstrating the direct 
involvement of larvae and toxocara toxins in the establishment and maintenance of hepatic cytolytic syndrome in children.
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produce about 200,000 eggs per day, and one gram of puppy 
feces can content around 100,000 eggs per gram. However, 
eggs need a few weeks to stay out of the host to mature and 
become invasive, so recently eliminated eggs are not dan-
gerous [9].
The basic classification of toxocarasis divides this pathol-
ogy depending on the affected organ. Thus, there are two 
basic syndromes: Larvas Migrans Visceralis (LMV) where 
pathology occurs with major organs damage and Migrans 
Larvas Ocular (OLM) [10] where the disease is limited to 
damage of the eye and the optic nerve [11]. The asymptom-
atic and occult form has also been described [12].
Clinical syndrome of LMV may be acute or subacute 
with splenomegaly, hepatomegaly, gastrointestinal symp-
toms, skin manifestations, pulmonary involvement, and 
CNS involvement (this particular form was called Neuro-
logical Toxocariasis) [13] and eosinophilia[14].
The occult form occurs as a result of the development 
of non-specific symptoms due to the action of the parasite 
antigen in the host’s immune system. Asymptomatic form 
is established when accidentally in patient without signs of 
typical damage are detected antibodies to Toxocara and eo-
sinophilia [15].
Multiple studies in this area, although most of the time 
having contradictory results, had a common element: the 
distribution of T. canis and T. cati is global, with cases 
identified in very limited populations. The seroprevalence 
rate ranges from less than 10% [16,17] to more than 80% 
[18,19,20], increased seroprevalence being more common 
in economically underdeveloped countries or countries in 
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developing cource[14,21]. Besides these well-known types, 
have also been discovered new varieties of Toxocara as Tox-
ocara  malayasiensis affecting domestic cats [22] and T. lyn-
cus infecting lynx [23]. However, there is no data on the in-
volvement of these new types discovered in human damage.
Children, due to childhood habits (especially geopha-
gia), poor personal hygiene, even if the children are part of 
families with a high income and good living standard, the 
tendency to contact with the animals, especially with pup-
pies without parental supervision, leads to an increased risk 
of receiving toxocariasis[15].
Material and methods
A prospective descriptive study was developed with the 
inclusion of 94 children aged 4 to 18 years with no other as-
sociated parasitosis (ascaridiasis, oxyuriasis, giardiasis, etc.). 
The patients were examined both clinically, with developing 
the most common clinical and paraclinical signs, revealing 
the general blood counts, biochemical examination (ALT 
and AST), total IgE level, antibody titre to T. canis.
Results and discussion
The study involved 94 children with Toxocara canis 
monoinvasion. Duration of toxocara invasion ranged from 
1 year to 9 years, in most children (70.1%) with a duration 
of 2 to7 years.
Among the studied group the average age was 11.4 ± 
0.47 years. Children aged 4-7 were 21 (22.3%), 8-12 years – 
36 (38.3%) and 13-18 years – 37 (39.4%).
The bronchopulmonary form prevailed with the in-
volvement of 32 children (34.0%) followed by the neurolog-
ical form with 30 children (31.9%), the cutaneous form was 
discovered in 16 children (17.0%), the digestive form – in 
10 children (10.5% %), and in 6 cases (7.3%) other clinical 
forms were described.
The frequency of major signs encountered during the 
course of the disease in children in the studied group is 
shown in fig. 1. Clinical manifestations behaved with a va-
riety of different intensity and frequency. The most frequent 
clinical manifestations in the studied group were headache 
and long-term cough, both in 33% of cases, followed with a 
decrease in percentage (from 25.5% to 20.3%) with hepato-
megaly, vertigo, abdominal pain, diffuse liver changes on ul-
trasound exam, skin pruritus, sleep disturbances. The other 
6 clinical signs with a decrease in percentage from 20% to 
10%: maculo-papular rash, splenomegaly, neuropsychiatric 
disorders (impulsivity, inability to concentrate, poor mem-
ory, chronic apathy, etc.), physical asthenia and weight loss 
(fig. 1).
Clinical manifestations with an incidence of less than 
10% in the course of chronic toxocariasis in children are 
shown in fig. 2. In 8.1% of cases of monoinvasion with T. 
canis were noted epileptiform seizures, signs of rhinitis and 
dyspnoea, in 6.8 % of cases is described bronchopneumo-
nia, in 5.4 cases – high level of ALT.
Fig. 1.  Percentage distribution of the most common signs in 
children with chronic visceral toxocariasis, monoinvasion.
Fig. 2.  Percentage distribution of the less common signs in 
children with chronic visceral toxocariasis, monoinvasion.
The specific treatment indicated in toxocariasis has been 
shown in most cases with benzimidazole derivatives with a 
2-times daily intake of 10 mg / kg / body with duration of 
10-14 days.
The number of leukocytes was not deviating from nor-
mal mean values, but significantly declined in patients with 
specific treatment from 6.8 ± 0.47 to 5.5 ± 0.47 (P <0.05). 
Also, the number of erythrocytes increased compared to 
the values  before the treatment, with statistical significance 
regardless of the specific treatment applied (P <0.001). 
The percentages of the lymphocytes had minor decreases 
compared to the baseline in the patients regardless of the 
therapy applied; however, they remained above the mean 
values  compared to the healthy ones. The percentage of eo-
sinophils, starting from over-normal values  compared to 
healthy subjects (6.3 ± 0.61 versus 1.8 ± 0.10, P <0.001), de-
creased regardless of the treatment applied to 3, 7 ± 1.0; in 
the absence of this treatment – 3.1 ± 0.76 (P <0.05).
In the group of children without specific treatment, ALT 
levels have increased significantly from baseline values and 
those seen in healthy individuals. In monoinvasion with 
T. canis, they increased from 23.8 ± 2.4 to 62.8 ± 14.2 (P 
<0.01). These liver enzyme behavioral findings demonstrate 
the direct involvement of larvae and toxocara toxins in the 
hepatic cytolytic syndrome. At the same time, the ALT ac-
tivity in the group with specific treatment remained close 
to the mean baseline values, no different from those seen in 
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healthy individuals, which proove the safety of antilarvaric 
treatment in children. Activity levels of the AST enzyme did 
not change during the different treatment regimens, and re-
mained constant within the normal mean values.
Paradoxically, however, regardless of treatment, levels of 
antibodies to T. canis increased, averaging higher than those 
found up to treatment.
The total IgE level was in the medium of 302.2 ± 41.0. 
Specific treatment had a beneficial effect on the evolution of 
total IgE, registering significantly lower values than baseline 
(145.4 ± 29.2 vs. 302.2 ± 41.0, P <0.01).
In order to identify the capacity of these children to form 
and maintain the postvaccinal response, randomly in every 
third child, with an average age of 9.18 ± 0.64 years, timely 
vaccinated according to the national vaccination schedule 
with three doses of the vaccine HepB, we tested the presence 
of anti-HBsAg in the serum. In these patients, the result was 
the titre of the protection antibodies below the detection 
limit, 1/3 of who were under the age of 7 years.
Because, as we mentioned, clinical manifestations were 
varied in intensity and frequency, the changes in the clinical 
picture during chronic toxocariasis in children were ana-
lyzed according to the percentage decrease of each symp-
tom, shown as a percentage of the intensity expressed be-
fore the onset of treatment applied. The average percentage 
reduction in symptoms determined clinical effectiveness. 
Thus, clinical efficacy was noted in terms of diminishing or 
negating clinical signs: very pronounced – efficacy noted 
with a reduction of 75%-100% of the intensity of previous 
manifestations, pronounced – 50-75%, poorly pronounced 
– less than 50% and absence. As observed in the study group, 
more pronounced and poorly pronounced clinical efficacy 
was found, and the lack of clinical efficacy was found only 
in 17.0% of the 94 tested children (P <0.01).
Out of the 94 children studied, antilarvaric specific 
treatment received 56 (59.6%) children and 38 (40.4%) did 
not receive this treatment. The very pronounced clinical ef-
ficacy in children with antilarvaric treatment was recorded 
in 16.1% of cases, whereas in the non-treated group only 
in 5.3% (P <0.05). Significant clinical efficacy was found in 
48.2% of the 56 treated versus 23.7% of the 38 without treat-
ment (P <0.05). And the percentage of those with specific 
treatment with poor clinical efficacy was higher – 23.2% 
versus 15.8%.
Lack of clinical efficacy was seen in 55.2% of children 
without specific therapy and only in 12.5% in those who re-
ceived this therapy (P <0.001).
The level of antibodies to T. canis in children in the in-
vestigated group receiving specific treatment decreased to 
31 (55.4%) compared to 18 (47.4%) found in those without 
specific therapy. However, after the anti-toxocara treatment, 
it was noted that in approximately one third of the patients 
the antibody levels increased (39.2%), although most of 
these children had expressed clinical improvement.
The percentage of eosinophils also had a greater de-
crease in children with specific treatment – 66.9%. Among 
the children with specific treatment, the cumulative per-
centage in increase or maintenance at the same eosinophil 
values was 30.4%, compared to 71.1% in the non-specific 
anti-toxocara treated group (P <0.001).
Total IgE concentration also declined more frequently 
among patients with anti-toxocara therapy – 33.9% of cases, 
compared with 26.3% in children without anti-toxocara 
treatment (P <0.001). The percentage of patients who did 
not experience essential changes was quite high, ranging 
from 42.3% to 48.2% (P <0.05).
Therefore, clinical manifestations of chronic toxocariasis 
in children are very numerous (more than 40 clinical signs), 
varying in intensity and incidence, and the most com-
mon of these are headache and dry cough, both of which 
are recorded in 33.0% of cases. In the investigated group 
hyper-eosinophilia is recorded in every 6-7th child, with 
a percentage of 13.5%. Summarizing the correlation of the 
laboratory indices in chronic toxocariasis in children, there 
is a decrease in the number of leukocytes, especially with 
applied specific antilarvar therapy (P <0.05). Parasitic offen-
sive action on laboratory indices was evident, demonstrat-
ing high levels of total IgE (302.2 ± 41.0 P <0.05) and eosin-
ophils (6.27 ± 0.61, P> 0, 05). Prolonged invasive parasitic 
action in children keeps the immune system permanently 
alert, contributing to the depletion of postvaccinal response 
formation and maintenance capacity.
Specific treatment significantly reduced the percentage 
of eosinophils and total IgE (P <0.01). The increase in ALT 
from 23.8 ± 2.4 to 62.8 ± 14.2 (P <0.01) in the absence of 
specific treatment, and maintenance of this enzyme within 
the normal range throughout the duration of the specific 
therapy demonstrates the direct involvement of the larvae 
and toxocara toxins in the development of hepatic cytolysis 
syndrome in children. The antibody levels to T. canis, re-
gardless of the treatment applied, tended to increase. The 
main laboratory indices that directly reflect parasitic ac-
tivity (the level of antibodies, total IgE and percentage of 
eosinophils) had a higher positive change frequency in the 
specific treated group (P <0.05). However, in approximately 
1/3 of the children with anti-toxocara treatment the an-
tibody titres increased (to 39.2%) and total IgE remained 
unchanged in 48.2% of cases, although most of them had 
apparent clinical improvement.
Conclusions
1. Clinical manifestations during chronic toxocariasis in 
children are very numerous (over 40 clinical signs); varying 
in intensity and incidence, the most common of them being 
headache, dry cough and abdominal pain. Blood hyper-eo-
sinophilia is recorded in every 6-7th child at a rate of 13.5%.
2. The specific therapy in chronic visceral toxocariasis 
in children had a much higher clinical rate, being reflected 
by maintaining the ALT level within the limits of normal 
values demonstrating the direct involvement of larvae and 
toxocara toxins in the occurrence and maintenance of he-
patic cytolysis syndrome in children.
3. Specific treatment significantly reduced the intensity 
of clinical manifestations, the percentage of eosinophils and 
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total IgE (P <0.01), much less acting on the level of antibod-
ies against Toxocara canis.
4. Toxocariasis in children takes the form of a complex 
evolutionary chronic process with periods of remissions, re-
lapses and exacerbations, which implies the need for further 
surveillance of these children, if necessary with the involve-
ment of other specialists (neurologist, ophthalmologist, 
etc.).
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